Lidothol Gel
Product Images NDC 83881-455

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidothol (NDC 83881-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinic Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lidothol Gel Carton Box (Lidothol Gel Box 123124)

Lidothol Gel Carton Box (Lidothol Gel Box 123124)
FDA Label Image

Package Insert (1) (Lidothol Package Insert 102424 01 (1))

Package Insert (1) (Lidothol Package Insert 102424 01 (1))
This text provides detailed information on the dosage and administration of Lidothol™ gel, including how to apply, handle, and store the product. It also covers potential adverse reactions, overdose management, drug interactions, and the description of the product's composition. Additionally, it mentions how Lidothol™ is absorbed and its pharmacological properties. The text advises on avoiding eye contact, discussing systemic reactions, and the supply details of the product. Contact information for Clinic Pharma is provided for further inquiries.*
FDA Label Image

Package Insert (2) (Lidothol Package Insert 102424 02 (1))

Package Insert (2) (Lidothol Package Insert 102424 02 (1))
This text provides detailed information about the distribution, metabolism, excretion, indications, contraindications, warnings, precautions, drug interactions, and potential adverse effects of Lidothol™, a medication used for pain relief associated with various conditions like arthritis, sprains, and strains. It highlights important points such as the risk of methemoglobinemia, considerations for dosing, contraindications in specific patient populations, and precautions related to application on non-intact skin or exposure to external heat sources. The text also includes guidance on monitoring for symptoms of methemoglobinemia, recommendations for patients with known sensitivities to anesthetics, and advice regarding eye exposure or allergic reactions. It provides a comprehensive overview for healthcare professionals or individuals considering the use of Lidothol™.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.